- New treatment options for ALK-positive patients with NSCLC krizotinibem2016 | Publication without faculty affiliation
- Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- A targeted diagnostic procedure and a treatment of an advanced lung carcinoma -the case report of a successful cooperation of four clinic departments, and crizotinib in a treatment of ROS 1 positive NSCLC2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Crizotinib - a novel multikinase inhibitor of signalling pathways for treatment in selected patients with non-small cell lung cancwer2013 | Faculty of Medicine in Pilsen
- Komentář ke studii: Aktuální data o účinnosti a bezpečnosti alektinibu vs. krizotinibu u nepředléčeného pokročilého ALK+ NSCLC - prodloužené sledování ve studii ALEX2018 | Second Faculty of Medicine
- Strategie léčby ALK-pozitivního NSCLC2018 | Second Faculty of Medicine
- ALK-driven non-small cell lung cancer: Prevention, prophylaxis, and treatment of brain metastases2021 | Faculty of Medicine in Pilsen
- Současné možnosti léčby ALK-pozitivního NSCLC2021 | First Faculty of Medicine
- Dlouhodobé přežívání pacientky s ALK pozitivním metastatickým adenokarcinomem plic2019 | First Faculty of Medicine
- Ceritinib - a new hope for patients with ALK-positive translocation of non-small-cell lung cancers2017 | Faculty of Medicine in Pilsen
- Komentář ke studii2019 | Second Faculty of Medicine
- Targeted therapy of non-small cell lung cancer2021 | Faculty of Medicine in Pilsen
- Profile of the drug Xalkori2014 | Faculty of Medicine in Pilsen
- Multidisciplinary approach to the lung adenocarcinoma treatment in a young patient2019 | Third Faculty of Medicine
- Lorlatinib in the treatment of non-small cell lung cancer2019 | Second Faculty of Medicine
- Lorlatinib in the treatment of non‑small cell lung cancer2020 | Publication without faculty affiliation
